Paraneoplastic hypoglyacemia

Česká verzia

Authors: I. Ságová; A. Klimentová; D. Prídavková; D. Kantárová; J. Sadloňová; P. Galajda; M. Mokáň
Authors place of work: I. interná klinika Jesseniovej lekárskej fakulty UK a UN Martin, Slovenská republika, prednosta prof. MU Dr. Marián Mokáň, DrSc., FRCP Edin.
Published in the journal: Vnitř Lék 2013; 59(5): 402-406
Category: Case Report

Summary

Paraneoplastic hypoglyacemia (PH) is a relatively rare phenomenon, which may be caused by insulinomas or non‑islet cell tumours (NICT). Both types are among the major “fasting” hypoglyacemia as opposed to reactive postprandial hypoglyacemia. The most common group of non‑islet cell tumours causing hypoaglycemia are large mesenchymal tumours, which account for over 50 % of all neoplasms associated with hypoglyacemia. Neuroglycopenic symptoms in patients with NICT may be present for months or years before the actual diagnosis of the underlying disease. Differentiation and correct diagnosis of this type of disease leads to significant improvement in the quality of life of these patients.

Key words:
paraneoplastic hypoaglycemia – non‑islet cell tumors – diagnosis – therapy

Zdroje

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GIST tumors): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 2003; 13: 157.

2. Angioli R, Battista C, Muzii L et al. A gastrointestinal stromal tumor presenting as a pelvic mass. Oncol Rep 2009; 21: 899– 902.

3. Groot J, Rikhof B, van Doorn J et al. Non‑ islet cell tumour‑induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 2007; 14: 979– 993.

4. Graadt van Roggena JF, Hogendoorn PCW. Solitary fibrous tumour: the emerging clinicopathologic spectrum of an entity and its differential diagnosis. Current Diagnostic Pathology 2004; 10: 229– 235.

5. Doege KW. Fibrosarcoma of the Mediastinum. Ann Surg 1930; 92: 955.

6. Potter RE. Intrathoracic tumors. Radiology 1930; 14: 60– 62.

7. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13: 640– 658.

8. Daughaday WH. Hypoglycemia due to paraneoplastic secretion of insulin growth factor‑ 1. J Clin Endocrinol Metab 2007; 92: 1616.

9. Pollak M. Insulin and insulin‑like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915– 928.

10. Daughaday WH, Trivedy B. Meaurement of derivates of proinsulin‑like growth factor‑ II in serum by radioimmunoassay directed againsthe E‑ domain in normal subjects and patients with noninslet cell tumor hyglycemia. J Clin Endocrinol Metab 1992; 75: 110– 115.

11. Pink D, Schoeler D, Lindner T et al. Severe hypoglycemia caused by paraneoplasticproduction of IGF‑II in patients with advanced gastrointestinal stromal tumors: a report of two cases. J Clin Oncol 2005; 23: 6809– 6811.

12. Mokáň M, Galajda P. Hypoglykémia pri vybraných vnútorných chorobách. Quickprint Martin 2011; 119 s.

13. de Boer Jager PL, Wiggers T, Nieboer P et al. The therapeutics challenge of a nonresectable solitary fibrou tumour of the pleura. Int J Clin Oncol 2006; 11: 478– 481.

14. Teale JD, Wark G. The effectiveness of different treatment options for non‑islet cell tumor hypoglycemia. Clin Endocrinol (Oxf.) 2004; 60: 457– 460.

15. Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinol Metab Clin North Am 1999; 28: 519– 532.

16. Service FJ. Classification of hypoglycemic disorders. Endocrinol Metab Clin North Am 1999; 28: 501– 517.

17. Lupsa BC, Chong AY, Cochran EK et al. Autoimmune Forms of Hypoglycemia. Medicine 2009; 88: 141– 153.

18. Waldron‑ Lynch F, Inzucchi SE, Menard L et al. Relapsing and Remitting Severe Hypoglycemia due to a Monoclonal gammapathy. Evidence for monoclonal insulin autoantibodies. Diabetes Care 1989; 12: 147– 150.

19. Mokáň M. Hypoglykémia. Vnitř Lék 2008; 54: 387– 394.

20. Kar P, Price P, Sawers S et al. Insulinomas may present with normogylcemia after prolonged fasting but glucose‑stimulated hypoglycemia. J Clin Endocrinoll Metab 2006; 91: 4733– 4736.